Sharon Bio- Medicines strengthens on completing expansion at three manufacturing facilities

02 Apr 2014 Evaluate

Sharon Bio-Medicine is currently trading at Rs. 42.35, up by 0.45 points or 1.07 % from its previous closing of Rs. 41.90 on the BSE.

The scrip opened at Rs. 43.00 and has touched a high and low of Rs. 43.30 and Rs. 42.15 respectively. So far 584467 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 57.95 on 21-Feb-2014 and a 52 week low of Rs. 27.27 on 20-Nov-2013.

Last one week high and low of the scrip stood at Rs. 43.90 and Rs. 40.00 respectively. The current market cap of the company is Rs. 447.59 crore.

The promoters holding in the company stood at 60.20 % while Non-Institutions held 39.80% of company’s stake.

Sharon Bio-Medicine has completed expansion in its three manufacturing facilities. The total investment in expansion has been incurred to the tune nearly Rs 125 crore. In Dehradun Formulation plant, the expanded expenditure has been around Rs 85 crore whereas capacity of the plant has been increased more than double. Similarly, other plants’ capacity has been added between 30-50%.

The commercial production in the company’s two expanded plants at Taloja near Navi Mumbai have already been started and Dehradun Formulation expanded facility will start production from June, 2014.

Sharon Bio-Medicine’s Toxicology Laboratories is an independent cost centre and is approved by Department of Science & Technology, Government of India. Government of India has approved Good Laboratory Certificate to SA-FORD which is valid as per OECD Countries - GLP studies.

Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×